Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PF-4136309

Generic Name: PF-4136309

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₃₁F_₃N_₆O_₃

CAS Number: 1341224-83-6

Unique Ingredient Identifier: 3M2595V4KT

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Phase 2

Terminated

Posted: 2016/04/11

Sponsor:Pfizer

ID:NCT02732938

Food Effect Study PF-04136309

Phase 1

Completed

Posted: 2015/11/05

Sponsor:Pfizer

ID:NCT02598206

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Phase 1

Completed

Posted: 2011/08/09

Sponsor:Washington Universit...

ID:NCT01413022

Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Phase 2

Terminated

Posted: 2010/10/22

Sponsor:Pfizer

ID:NCT01226797

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Phase 2

Completed

Posted: 2008/06/03

Sponsor:Pfizer

ID:NCT00689273

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy